Yunxia Sui Sign in to save

OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (6)

2× Medical, AbbVie, Inc, North Chicago, États-Unis
1× Immunology, AbbVie Inc, North Chicago, Illinois, USA
1× AbbVie North Chicago Illinois United States
1× Abbvie Inc. [North Chicago] (1400 Sheridan Rd, North Chicago, IL 60064 - United States)
1× AbbVie Inc, North Chicago, Illinois, USA
1× AbbVie Inc., Rheumatology, North Chicago, United States of America

Papers 6 stored

All · Aachen affiliation only

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access

129

citations
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
2022 RMD Open article Medicine Spondyloarthritis Studies and Treatments Open access

50

citations
Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante active : résultats à 2 ans d’une étude randomisée, en double aveugle, contrôlée versus placebo avec extension en ouvert
2021 Revue du Rhumatisme article Medicine Spondyloarthritis Studies and Treatments

0

citations
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One‐Year Results of a Double‐Blind, Placebo‐Controlled Study and Open‐Label Extension
2021 Arthritis & Rheumatology article Medicine Spondyloarthritis Studies and Treatments Open access

66

citations
OP0144 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 1-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
2021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments

0

citations
Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante active : résultats à 1 an d’une étude randomisée, en double aveugle, contrôlée versus placebo, avec extension en ouvert
2020 Revue du Rhumatisme article Medicine Spondyloarthritis Studies and Treatments

0

citations

6 results

Yunxia Sui ▲ Sign in to save

Departments & institutes in Aachen

Papers 6 stored

Yunxia Sui Sign in to save